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ischemia (in order to avoid any effect on ischemic and/or early 
reperfusion injury) with an E2-releasing pellet (80 g/kg/day). 
Coronary segments (internal diameter 180 to 220 m) were removed 
distal to the site of occlusion and mounted in a wire myograph to 
study the relaxing response to acetylcholine (Ach).
At 24 hours reperfusion (i.e. immediately before the onset of E2 
treatment), OVX mice displayed a marked endothelial dysfunction 
(maximal relaxation to Ach: sham 55+/-4 ; IR 31+/-4 % ; p<0.05). One 
month after reperfusion, untreated OVX mice showed a persistent 
decreased relaxation, whereas chronic E2 markedly increased the 
relaxing responses in IR mice (to a level similar to that of untreated 
sham mice) (Figure). E2 also slightly increased the relaxing 
responses in sham mice. In vitro NO Synthase inhibition abolished 
the differences between mice, suggesting that E2 restored the 
decreased NO production induced by IR.
We thus demonstrate for the  rst time a marked bene cial effect 
of E2 on coronary endothelial healing after chronic reperfusion, 
leading to a restoration of coronary endothelial function.
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Objectives — We aimed to determine whether mechanical 
dyssynchrony assessed by Equilibrium RadioNuclide Angiography 
(ERNA) may predict response to CRT.
Methods — 70 patients were consecutively enrolled. ERNA, 
echocardiography and electrocardiogram were performed before 
biventricular pacemaker implantation. Positive response to CRT 
was de ned as an improvement in NYHA class in patients alive and 
not readmitted for HF within 6 months.
Results — Mean age was 65±9 years, 74 % of patients were men, 
84 % were in NYHA class III or IV. Main HF aetiologies were ischemic 
(36 %) or dilated (50 %). ERNA left ventricular ejection fraction was 
21±9 %, QRS duration was 161±34 ms. 96 % of patients received an 
ACE inhibitor or an angiotensin II receptor antagonist, 66 % a beta-
blocker and 36 % an aldosterone antagonist. Non-response rate was 
31.5 %. Interventricular delay assessed by ERNA was greater in non-
responders versus responders in univariate analysis: respectively 
92±39 ms and 57±46 ms, p = 0.005. QRS duration, interventricular 
and intraventricular delay assessed by echocardiography, 
intraventricular delay assessed by ERNA, were not signi cantly 
different between the two groups.
In conclusion, by contrast to other methods, interventricular 
delay assessed by ERNA before implantation may help to identify 
responders and non-responders to CRT.
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A recent study in Shaker, a voltage-dependent potassium channel, 
suggests a coupling between activation and inactivation. This 
coupling is controversial in hERG, a fast-inactivating voltage-
dependent potassium channel. To address this question, we 
transferred to hERG the S3-S4 linker of the voltage-independent 
channel, rolf, in order to selectively disrupt the activation process. 
This chimera shows an intact voltage-dependent inactivation 
process consistent with a weak coupling, if any, between both 
processes. Kinetic models suggest that the chimera presents only 
an open and an inactivated states, with identical transition rates 
as in hERG. The lower sensitivity of the chimera to BeKm-1, a 
hERG preferential closed-state inhibitor, con rms that the chimera 
exists only in open or inactivated conformations. This chimera 
allows determining the mechanism of action of hERG blockers, as 
exempli ed by the test on ketoconazole.
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Background & Aim — Reduced cardiac repolarizing K+ currents, 
mainly IKr (hERG) and IKs, prolong the duration of the QTinterval, 
which is a hallmark of the congenital long QT syndrome (LQTS). In 
this study, a novel heterozygous mutation in the hERG gene was 
discovered in a 37-year-old woman with history of Torsades de 
pointes and prolonged QTc. Here, we characterized the 7  amino-
acid duplication (343 363dup) located in the PAS domain at hERG 
N-terminus.
Results — Since the duplication is in the PAS domain, which is 
involved in deactivation of hERG, we  rst studied this process using 
the patch-clamp method in CHO cells expressing wild-type (WT) and 
mutant (Dupl) hERG channels. The main deactivation time constant 
was reduced by 1.4—1.8-fold for hERG Dupl compared to WT in tail 
currents recorded at -150 and -90 mV, respectively. Deactivation-
